Plasma visfatin/nicotinamide phosphoribosyltransferase levels in hypertensive elderly - Results from the PolSenior substudy

Journal of the American Society of Hypertension

Volumn 9, Issue 1, 2015, Pages 1-8

  Kocelak, Piotr ^a   Olszanecka Glinianowicz, Magdalena ^a   Owczarek, Aleksander ^a   Bozentowicz Wikarek, Maria ^a   Brzozowska, Aniceta ^a   Mossakowska, Małgorzata ^b   Zdrojewski, Tomasz ^c   Grodzicki, Tomasz ^d   Więcek, Andrzej ^a   Chudek, Jerzy ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b INTERNATIONAL INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Poland)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

^d JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Aging; antihypertensive treatment; hypertension; microinflammation

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INTERLEUKIN 6; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; CYTOKINE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, HUMAN;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VERY ELDERLY; AGE; BLOOD; INFLAMMATION; INSULIN RESISTANCE; MULTIVARIATE ANALYSIS; PHYSIOLOGY;

AGE FACTORS; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; MALE; MULTIVARIATE ANALYSIS; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

EID: 84923105223     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2014.11.002     Document Type: Article

References (53)

1. H.J. Foulds, S.S. Bredin, and D.E. Warburton The relationship between hypertension and obesity across different ethnicities J Hypertens 30 2012 359 367
2. R.N. Re Obesity related hypertension Ochsner J 9 2009 133 136
3. A. Da Silva, J. do Cormo, J. Dubinion, and J.E. Hall Role of sympathetic nervous system in obesity related hypertension Curr Hypertens Rep 11 2009 206
4. M. Olszanecka-Glinianowicz, and B. Zahorska-Markiewicz Obesity as inflammatory disease Postepy Hig Med Dosw (Online) 62 2008 249 257
5. J. Chudek, and A. Więcek Adipose tissue, inflammation and endothelial dysfunction Pharmacol Rep 58 Suppl 2006 81 88
6. M. Adamczak, and A. Wiecek The adipose tissue as an endocrine organ Semin Nephrol 33 2013 2 13
7. M. Vlasova, A. Purhonen, M. Jarvelin, E. Rodilla, J. Pascual, and K. Herzig Role of adipokines in obesity-associated hypertension Acta Physiol 200 2010 107 127
8. C. Rüster, and G. Wolf Adipokines promote chronic kidney disease Nephrol Dial Transplant 28 2013 iv8 iv14
9. T. Wang, X. Zhang, P. Bheda, J.R. Revollo, S. Imai, and C. Wolberger Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme Nat Struct Mol Biol 13 2006 661 662
10. V. Varma, A. Yao-Borengasser, N. Rasouli, A.M. Bodles, B. Phanavanh, and M.J. Lee Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation J Clin Endocrinol Metab 92 2007 666 672
11. B.L. Wajchenberg Subcutaneous and visceral adipose tissue: their relation to metabolic syndrome Endocr Rev 21 2000 697 738
12. D. Friebe, M. Neef, J. Kratzsch, S. Erbs, K. Dittrich, and A. Garten Leukocytes are a major source of circulating nicotinamide phosphoribosyltransferaze (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans Diabetologia 4 2011 1200 1211
13. S. Vallejo, T. Romacho, J. Angulo, L. Villalobos, E. Cercas, and A. Leivas Visfatin impairs endothelium-dependent relaxation in rat and human mesenteric microvessels through nicotinamide phosphoribosyltransferase activity PLoS One 6 2011 e27299
14. S.R. Kim, Y.H. Bae, S.K. Bae, K.S. Choi, K. Yoon, and T. Koo Visfatin enhances ICAM-1 and VCAM-1 expression through ros-dependent NF-kappaB activation in endothelial cells Biochim Biophys Acta 1783 2008 886 895
15. A.E. Schutte, H.W. Huisman, R. Schutte, J.M. van Rooyen, L. Malan, and C.M. Fourie Adipokines and cardiometabolic function: How are they interlinked? Regul Pept 164 2010 133 138
16. R. Adya, B.K. Tan, J. Chen, and H.S. Randeva Nuclear factor-kappaB induction by visfatin in human vascular endothelial cells: its role in MMP-2/9 production and activation Diabetes Care 31 2008 758 760
17. S.W. Liu, S.B. Qiao, J.S. Yuan, and D.Q. Liu Visfatin stimulates production of monocyte chemotactic protein-1 and interleukin-6 in human vein umbilical endothelial cells Horm Metab Res 41 2009 281 286
18. M. Xia, C. Zhang, K.M. Boini, A.M. Thacker, and P.L. Li Membrane raft-lysosome redox signalling platforms in coronary endothelial dysfunction induced by adipokine visfatin Cardiovasc Res 89 2011 401 409
19. T. Romacho, V. Azcutia, M. Vázquez-Bella, N. Matesanz, E. Cercas, and J. Nevado Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity Diabetologia 52 2009 2455 2463
20. T. Dogru, A. Sonmez, I. Tasci, E. Bozoglu, M.I. Yilmaz, and H. Genc Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance Diabetes Res Clin Pract 76 2007 24 29
21. F. Gunes, E. Akbal, E. Cakir, O. Akyurek, M. Altunbas, and M. Ozbek Visfatin may be a novel marker for identifying stages of essential hypertension in advanced age patients Intern Med 51 2012 553 557
22. S. Rotkegel, J. Chudek, U. Spiechowicz-Zaton, R. Ficek, M. Adamczak, and A. Wiecek The effect of sodium restricted diet on plasma visfatin levels in hypertensive patients with visceral obesity Kidney Blood Press Res 37 2013 124 131
23. A. Korner, A. Garten, M. Bluher, R. Tauscher, J. Kratzsch, and W. Kiess Molecular Characteristics of serum visfatin and differential detection by immunoassays J Clin Endocrinol Metab 92 2007 4783 4791
24. Zdrojewski T, Wizner B, Więcek A, ͆lusarczyk P, Chudek J, Mossakowska M, et al. Prevalence, awareness and control of hypertension in elderly and very elderly in Poland - results of a cross-sectional representative survey. J Hypertens [in press].
25. P. Błedowski, M. Mossakowska, J. Chudek, T. Grodzicki, A. Milewicz, and A. Szybalska Medical, psychological, social, and economic aspects of aging in Poland (PolSenior): research assumptions and objectives Exp Gerontol 46 2011 1003 1009
26. P. Nadrowski, J. Chudek, T. Grodzicki, M. Mossakowska, M. Skrzypek, and A. Wiecek Plasma level of N-terminal pro brain natriuretic peptide (NT-proBNP) in elderly population in Poland - The PolSenior Study Exp Gerontol 48 2013 852 857
27. G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, and G. Germano Guidelines for the Management of Arterial Hypertension: ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) J Hypertens 25 2007 1105 1187
28. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Sep 2000;894:1-253.
29. K.G. Alberti, P. Zimmet, and J. Shaw Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation Diabet Med 23 2006 469 480
30. A.S. Levey, L.A. Stevens, C.H. Schmid, Y.L. Zhang, A.F. Castro 3rd, H.I. Feldman CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) A new equation to estimate glomerular filtration rate Ann Intern Med 150 2009 604 612
31. M.J. Hosseinzadeh Atar, H. Hajianfar, and A. Bahonar The effects of omega-3 on blood pressure and the relationship between serum visfatin level and blood pressure in patients with type II diabetes ARYA Atheroscler 8 2012 27 31
32. C. Benedict, A. Shostak, T. Lange, S.J. Brooks, H.B. Schioth, and B. Schultes Diurnal rhythm of circulating nicotinamide phosphoribosyltransferase (Nampt/visfatin/PBEF): impact of sleep loss and relation to glucose metabolism J Clin Endocrinol Metab 97 2012 E218 E222
33. D. de Luis, M. Gonzales Sagrado, R. Conde, R. Aller, O. Izaola, and E. Romero Effect of hypocaloric diet on serum visfatin in obese non-diabetic patients Nutrition 24 2008 517 521
34. M. Olszanecka-Glinianowicz, P. Kocełak, J. Janowska, A. Skorupa, M. Nylec, and B. Zahorska-Markiewicz Plasma visfatin and tumor necrosis factor-alpha (TNF-α) levels in metabolic syndrome Kardiol Pol 69 2011 802 807
35. E. Ingelsson, M. Larson, C. Fox, X. Yin, T. Wang, and I. Lipinska Clinical correlates of circulating visfatin levels in a community based simple Diabetes Care 30 2007 1278 1280
36. M. Olszanecka-Glinianowicz, P. Kocełak, M. Nylec, J. Chudek, and B. Zahorska-Markiewicz Circulating visfatin level and visfatin/insulin ratio in obese women with metabolic syndrome Arch Med Sci 8 2012 214 218
37. W. Pang, E.A. Price, D. Sahoo, I. Beerman, W.J. Maloney, and D.J. Rossi Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age Proc Natl Acad Sci USA 108 2011 20012 20017
38. J. Plowden, M. Renshaw-Hoelscher, C. Engleman, J. Katz, and S. Sambhara Innate immunity in aging: impact on macrophage function Aging Cell 3 2004 161 167
39. J. Chudek, K. Wieczorowska-Tobis, J. Zejda, K. Broczek, A. Skalska, and T. Zdrojewski The prevalence of chronic kidney disease and its relation to socioeconomic conditions in the elderly Polish population: results from the national population-based study PolSenior Nephrol Dial Transplant 29 2014 1073 1082
40. M.P. Chen, F.M. Chung, D.M. Chang, J.C. Tsai, H.F. Huang, and S.J. Shin Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus J Clin Endocrinol Metab 91 2006 295 299
41. K.C. Lewandowski, N. Stojanovic, M. Press, S.M. Tuck, K. Szosland, and M. Bienkiewicz Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance Diabetologia 50 2007 1033 1037
42. D.G. Haider, G. Schaller, S. Kapiotis, C. Maier, A. Luger, and M. Wolzt The release of the adipocytokine visfatin is regulated by glucose and insulin Diabetologia 49 2006 1909 1914
43. L. Niepolski, A. Grzegorzewska, and M. Młot-Michalska Visfatin and endogenous secretory receptor for advanced glycation end-products in diabetic type 2 and non-diabetic patients undergoing intermittent hemodialysis Int Urol Nephrol 42 2010 441 452
44. A. Lopez-Bermejo, B. Chico-Julia, M. Fernandez-Balsells, M. Recasens, E. Esteve, and R. Casamitjana Serum visfatin increases with progressive cell deterioration Diabetes 55 2006 2871 2875
45. J.R. Revollo, A. Körner, K.F. Mills, A. Satoh, T. Wang, and A. Garten Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme Cell Metab 6 2007 363 375
46. J.R. Sowers Insulin resistance and hypertension Am J Physiol Heart Circ Physiol 286 2004 H1597 H1602
47. H.D. Sesso, J.E. Buring, N. Rifai, G.J. Blake, J.M. Gaziano, and P.M. Ridker C-reactive protein and the risk of developing hypertension JAMA 290 2003 2945 2951
48. S.K. Venugopal, S. Deveraj, I. Yuhanna, P. Shaul, and I. Jialal Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells Circulation 106 2002 1439 1441
49. M. Furuhashi, N. Ura, H. Takizawa, D. Yoshida, N. Moniwa, and H. Murakami Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity J Hypertens 22 2004 1977 1982
50. A. Storka, E. Vojtassakova, M. Mueller, S. Kapiotis, D.G. Haider, and A. Jungbauer Angiotensin inhibition stimulates PPARgamma and the release of visfatin Eur J Clin Invest 38 2008 820 826
51. K.C. Choi, O.H. Ryu, K.W. Lee, H.Y. Kim, J.A. Seo, and S.G. Kim Effect of PPAR-a and -c agonist on the expression of visfatin, adiponectin, and TNF-a in visceral fat of OLETF rats Biochem Biophys Res Commun 336 2005 747 753
52. G. Winkler, and K. Cseh Molecular mechanisms and correlations of insulin resistance, obesity, and type 2 diabetes mellitus Orv Hetil 150 2009 771 780
53. M. Olszanecka-Glinianowicz, B. Zahorska-Markiewicz, J. Janowska, and A. Zurakowski Serum concentrations of nitric oxide, tumor necrosis factor (TNF)-alpha and TNF soluble receptors in women with overweight and obesity Metabolism 53 2004 1268 1273